Region-Specific, Life-Threatening Diseases among International Travelers from Israel, 2004–2015

Region-Specific, Life-Threatening Diseases among International Travelers from Israel, 2004–2015

We characterized posttravel hospitalizations of citizens returning to Israel by summarizing the returning traveler hospitalization dataset of the national referral Center for Travel Medicine and Tropical Diseases at Sheba Medical Center in Israel. Of 722 hospitalizations, 181 (25%) infections were l...

Full description

Bibliographic Details
Main Authors:	Chen Avni, Shmuel Stienlauf, Eyal Meltzer, Yechezkel Sidi, Eli Schwartz, Eyal Leshem
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2018-04-01
Series:	Emerging Infectious Diseases
Subjects:	posttravel hospitalization vaccination malaria chemoprophylaxis life-threatening prophylaxis
Online Access:	https://wwwnc.cdc.gov/eid/article/24/4/17-1542_article

Similar Items

Malaria in the 21st century - still a threatening problem
by: Čanović Predrag, et al.
Published: (2019-01-01)

Travel-Related Tick-Borne Encephalitis, Israel, 2006–2014
by: Eyal Meltzer, et al.
Published: (2017-01-01)

Survey and Analysis of Chemoprophylaxis Policies for Domestic Travel in Malaria-Endemic Countries
by: John Kevin Baird, et al.
Published: (2022-06-01)

Evidence of malarial chemoprophylaxis among travellers who died from malaria: a systematic review and meta-analysis
by: Manas Kotepui, et al.
Published: (2023-11-01)

Management of Plasmodium vivax risk and illness in travelers
by: J. Kevin Baird
Published: (2017-03-01)

Imported cases of malaria in Spain: observational study using nationally reported statistics and surveillance data, 2002–2015
by: Zaida Herrador, et al.
Published: (2019-07-01)

Quimioprofilaxia da malária com mefloquina na amazônia brasileira
by: João Barberino Santos, et al.
Published: (1993-09-01)

Molecular markers of resistance to amodiaquine plus sulfadoxine–pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger
by: Rebecca F. Grais, et al.
Published: (2018-02-01)

Hair concentrations of anti-malarials in returned travellers-the HAIR study: Proof of principle analysis
by: Regula Steiner, et al.
Published: (2023-07-01)

Efficiency of antimalarial chemoprophylaxis – an analysis of malaria morbidity among members of section for tropical medicine, medical faculty of Ljubljana, on electives in third world countries 1990–2005
by: Urška Bokal, et al.
Published: (2007-05-01)

Imported Plasmodium vivax malaria complicated by reversible myocarditis
by: Fahmi Y Khan
Published: (2019-01-01)

Travel-related Schistosomiasis Acquired in Laos
by: Eyal Leshem, et al.
Published: (2009-11-01)

Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
by: Shmuel Stienlauf, et al.
Published: (2009-07-01)

PROPHYLAXIS OF MALARIA
by: Eli Schwartz
Published: (2012-06-01)

Chemoprophylaxis of Tropical Infectious Diseases
by: William J. H. McBride
Published: (2010-05-01)

Asymptomatic malaria parasitaemia in sickle-cell disease patients: how effective is chemoprophylaxis ?
by: Rachel Kotila, et al.
Published: (2007-03-01)

An open label study of the safety and efficacy of a single dose of weekly chloroquine and azithromycin administered for malaria prophylaxis in healthy adults challenged with 7G8 chloroquine-resistant Plasmodium falciparum in a controlled human malaria infection model
by: Jeffrey Livezey, et al.
Published: (2020-09-01)

Zika Virus Disease in Traveler Returning from Vietnam to Israel
by: Eyal Meltzer, et al.
Published: (2016-08-01)

Chemoprophylaxis and Malaria Death Rates
by: Gérard Krause, et al.
Published: (2006-03-01)

A systematic review of factors affecting adherence to malaria chemoprophylaxis amongst travellers from non-endemic countries
by: Julian Ahluwalia, et al.
Published: (2020-01-01)

An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++
by: Liesbeth F Mieras, et al.
Published: (2018-10-01)

Imported Melioidosis, Israel, 2008
by: Avivit Cahn, et al.
Published: (2009-11-01)

Community engagement among forest goers in a malaria prophylaxis trial: implementation challenges and implications
by: Franca Conradis-Jansen, et al.
Published: (2023-06-01)

Utilization patterns of malaria chemoprophylaxis among Tanzanian children attending sickle cell clinic in Dar es Salaam tertiary hospitals
by: Esther J. Ndegeulaya, et al.
Published: (2019-12-01)

Markers of sulfadoxine–pyrimethamine resistance in Eastern Democratic Republic of Congo; implications for malaria chemoprevention
by: Marit van Lenthe, et al.
Published: (2019-12-01)

Sickle cell disease and malaria: decreased exposure and asplenia can modulate the risk from Plasmodium falciparum
by: Richard O. Mwaiswelo, et al.
Published: (2020-04-01)

Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis
by: Delphine Laho, et al.
Published: (2021-08-01)

Prophylaxis Failure and Successful Management of Delayed-Onset Malaria with Renal Complications: A Case Report with Oral Artemether-Lumefantrine Treatment
by: Ilir Tolaj, et al.
Published: (2023-11-01)

Plasmodium falciparum Merozoite Surface Protein-1 Polymorphisms among Asymptomatic Sickle Cell Anemia Patients in Nigeria
by: Iwalokun Bamidele Abiodun, et al.
Published: (2016-02-01)

Safety and effectiveness of antimalarial therapy in sickle cell disease: a systematic review and network meta-analysis
by: Augustina Frimpong, et al.
Published: (2018-12-01)

A study on comparative efficacy of anti tubercular chemoprophylaxis with 2 different regimens: 2 months of rifampicin and pyrazinamide and 6 months of daily isoniazid and rifampicin in HIV infected tuberculin reactors
by: Prasad BNBM
Published: (2006-01-01)

The Role of Pharmacists in Travel Medicine in South Africa
by: Lee Baker
Published: (2018-07-01)

Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trial
by: Darrell H. S. Tan, et al.
Published: (2021-03-01)

Adolescents Traveling to High-Risk Destinations: Review and Considerations for Clinicians
by: Helena Maltezou, et al.
Published: (2018-12-01)

Suspected Severe Malaria in a Sudanese Patient Affected by Sickle Cell Disease Who Was Treated with Hydroxyurea
by: Giulia Chiopris, et al.
Published: (2021-08-01)

The need for preventive and curative services for malaria when the military is deployed in endemic overseas territories: a case study and lessons learned
by: Sumadhya Deepika Fernando, et al.
Published: (2017-06-01)

Risk for Emergence of Dengue and Chikungunya Virus in Israel
by: Eyal Leshem, et al.
Published: (2012-02-01)

Adherence to malaria prophylaxis among travelers from a middle-income country
by: Karis Maria de Pinho Rodrigues, et al.

Malaria Prophylaxis and Vaccinations Among Turkish International Travelers: National Data, 2011-2016
by: Gülay OKAY, et al.
Published: (2019-07-01)

Emerging prophylaxis strategies against COVID-19
by: Sumita Agrawal, et al.
Published: (2020-03-01)